Pipeline

Publicly funded programs

Alternative metal binding groups in drugs for the treatment of periodontitis - AMePA

Read More

Controlled release drug delivery systems of innovative and selective drug molecules for the treatment of bacterial infectious diseases of the periodontum – ParoStop

Read More

Profiling inhibitors of bacterial glutaminyl cyclases as drug prototypes of novel periodontal therapeutics - PInParo

Read More

Awards

Investments By

Publications

Extrudates of lipophilic tetracycline complexes: A new option for periodontitis therapy 2019
https://www.sciencedirect.com/science/article/pii/S0378517319308397
  Controlled release minocycline-lipid-complex extrudates for the therapy of periodontitis with enhanced flexibility 2020
https://www.sciencedirect.com/science/article/pii/S0378517320305627
  In Vitro Evaluation of Antimicrobial Activity of Minocycline Formulations for Topical Application in Periodontal Therapy 2020
https://www.mdpi.com/1999-4923/12/4/352
  Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis 2021
https://www.sciencedirect.com/science/article/pii/S0021925821000302  
Tetrahydroimidazo[4,5-c]pyridine-Based Inhibitors of Porphyromonas gingivalis Glutaminyl Cyclase 2021
https://www.mdpi.com/1372046